MUPIROCIN
Generic: MUPIROCIN
Padagis Israel Pharmaceuticals LtdManufacturer
TOPICALRoute
MUPIROCINActive Substance
2003-11-07Original Approval
MUPIROCIN is FDA application ANDA065123, sponsored by PADAGIS ISRAEL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Mupirocin Ointment, USP 2%, 22 grams tube, Rx only, MFG: Teva Pharma USA, NDC 0093-1010-42, MFG: Teva Pharma USAcGMP deviations: Temperature abuse
Class II2024-08-30
Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513,Subpotent Drug
Top Reported Reactions
1
DRUG INEFFECTIVE
1,592 reports
2
OFF LABEL USE
1,004 reports
3
NAUSEA
974 reports
4
PAIN
948 reports
5
PRODUCT USE IN UNAPPROVED INDICATION
906 reports
6
FATIGUE
841 reports
7
MACULAR DEGENERATION
821 reports
8
HEADACHE
787 reports
9
DIARRHOEA
722 reports
10
RASH
635 reports